Status:
COMPLETED
Evaluation of Clinical Efficacy of Pentoxifylline on Patients With Glomerulonephritis
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Primary Glomerulonephritis
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
we hypothesize that PTX might be effective in lowering proteinuria by modulating renal MCP-1 production in human glomerulonephritis.
Detailed Description
Pentoxifylline (PTX) is a phosphodiesterase inhibitor that is widely used for the treatment of peripheral vascular occlusive disorders. In addition, PTX has shown its ability to attenuate nephrotic sy...
Eligibility Criteria
Inclusion
- glomerular diseases with subnephrotic proteinuria
Exclusion
- DM, hepatitis, systemic immunologic renal diseases
Key Trial Info
Start Date :
January 1 2000
Trial Type :
INTERVENTIONAL
End Date :
June 1 2001
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00154661
Start Date
January 1 2000
End Date
June 1 2001
Last Update
September 12 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yung-Ming Chen
Taipei, Taiwan, 100